Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

Disease Area Trends

Recent Tweets

CVN293 published by Cerevance in ACS Medicinal Chemistry Letters.

More Info: https://pryzm.ozmosi.com/product/29258 $XBI $IBB $XPH $PPH

$ENLV Enlivex starts Phase I/II trial for Allocetra™ in Knee Osteoarthritis patients with dosing of first two patients.

More Info: https://pryzm.ozmosi.com/product/19291 $XBI $IBB $XPH $PPH

ORYZON has obtained a new patent for its main CNS drug, Vafidemstat, solidifying its position in the market.

More Info: https://pryzm.ozmosi.com/product/20725 $XBI $IBB $XPH $PPH

$OCUP Ocuphire Pharma to present APX3330 at ARVO 2024 Annual Meeting.

More Info: https://pryzm.ozmosi.com/product/19799 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762